Zusammenfassung
Die von anderen Autoren festgestellten Erhöhungen des Serum-Erythropoetin-Spiegels bei Behandlung verschiedener Anämieformen mit Testosteron oder Fluoxymesteron konnten bei der Behandlung 8 anämischer Patienten mit Mesterolon oder Oxymetholon nicht bestätigt werden.
Summary
The increased levels of serum-erythropoietin which were reported by several authors in various forms of anemias treated with testosterone or fluoxymesterone could not be found in 8 anemic patients treated with mesterolone or oxymetholone.
Literatur
Alexanian, R.: Urinary excretion of erythropoitin in normal men and women. Blood28, 344 (1966).
Alexanian, R.: Erythropoietin and erythropoiesis in anemic men following androgens. Blood33, 564 (1969).
Allen, D. M., M. H. Fines, T. F. Necheles and W. Dameshek: Oxymetholone therapy in aplastic anemia. Blood32, 83 (1968).
Björntorp, P., A. Weinfeld and P. Lundin: A case of aplastic anemia successfully treated with androgens. Acta Med. Scand.177, 275 (1965).
Duarte, L., L. S. Medal, J. Labardini and L. Arriaga: The erythropoietic effects of anabolic steroids. Proc. Soc. Exper. Biol. Med.125, 1030 (1967).
Fried, W., R. De Gowin and C. W. Gurney: Erythropoietin effect of testosterone in polycytaemic mice. Proc. Soc. Exp. Biol. Med.117, 839 (1964).
Gardner, F. H. and J. C. Pringle: Androgens and erythropoiesis. I. Preliminary clinical observations. Arch. Int. Med.107, 846 (1961).
Gardner, F. H. and J. C. Pringle: Androgens and erythropoiesis. II. Treatment of myeloid metaplasia. New. Engl. J. Med.264, 103 (1961).
Gardner, H. and D. G. Nathan: Androgens and erythropoiesis. III. Further evaluation of testosterone treatment of myelofibrosis. New. Engl. J. Med.274, 420 (1966).
Gardner, F. H., D. G. Nathan, S. Piomelle and J. F. Cummins: The erythraemic effect of androgens. Brit. J. Haemat.14, 611 (1968).
Gurney, C. W. and W. Fried: Further studies on the erythropoietic effect of androgens. J. Lab. Clin. Med.65, 775 (1965).
Kennedy, B. J.: Androgenic hormone therapy in lymphatic leukemia. J. A. M. A.190, 1130 (1964).
Kennedy, B. J.: Stimulation of haematopoiesis by androgenic hormones. Geriatrics20, 808 (1965).
Mirand, E. A., A. S. Gordon and J. Wenig: Mechanism of testosterone action in erythropoiesis. Nature206, 290 (1965).
Moores, R. R., C. S. Wright, L. R. Collins, E. Gardner, J. P. Lewis and L. L. Smith: Stimulation of erythropoietin by androgen in the human. Scand. J. Haemat.5, 415 (1968).
Naets, J. P. and M. Wittek: Mechanism of action of androgens on erythropoiesis. Amer. J. Physiol.210/2, 315 (1966).
Najean, Y., C. Dresch, G. Schaison, J. Chassigneux, C. Jacquillat and J. Bernard: Etude de l'effet de l'androgenothérapie au cours des insuffisances médullaires. La presse medicale74, 2537, (1966).
Rishpon-Meyerstein, N., T. Kilbridge, J. Simone and W. Fried: The effect of testosterone on erythropoinetin. Blood31, 453 (1968).
Sanchez-Medal, L., A. Gomez-Leal and L. Duarte-Zapata: Anabolic therapy in aplastic anemia (Summary). Blood28, 979 (1966).
Schmid, J. R., J. M. Kiely, G. L. Pease and M. M. Hargraves: Acquired pure red cell agenesis. Report of 16 cases and review of the literature. Acta haemat. Basel30, 255 (1963).
Shahidi, N. T. and L. K. Diamond: Testosterone induce remission in aplastic anemia. Amer. J. Dis. Ch.98, 293 (1959).
Shahidi, N. T. and L. K. Diamond: Testosterone induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases. New Engl. J. Med.264, 953 (1961).
Shirakura, T., M. Azuma and T. Maekawa: Studies on erythropoietic actions of testosterone. Acta haemat.38, 49 (1967).
Steinglass, P., A. S. Gordon and H. A. Charipper: Effect of castration and sex hormones on the blood of rats. Proc. Soc. Exp. Biol. Med.48, 169 (1941).
Zittoun, R., A. Bernadou, C. M. Blanc, G. Bilski-Pasquier and J. Bousser: La metenolone dans le traitement des insuffisances médullaires. La presse medicale76, 445 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neumann, E., Honetz, N. & Wurm, B. Zum Verhalten des Erythropoetins bei aregeneratorischen Blutbildungsstörungen unter Therapie mit anabolen Steroiden. Blut 29, 373–381 (1974). https://doi.org/10.1007/BF01633672
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01633672